Detection method of mixture for tonifying spleen and dispelling effects of alcohol

Through thin-layer identification and liquid chromatography detection of the spleen-enhancing alcohol mixture, the proportion of ingredients of the mixture is ensured, and the existing problems of alcohol-intoxicating drugs are difficult to improve specific symptoms, so as to understand the liver-enhancing spleen, protect the liver and strengthen the spleen. Improves the speed of recovery of patients and the quality of life.

CN118937529AActive Publication Date: 2024-11-12HAIAN HOSPITAL OF TRADITIONAL CHINESE MEDICINE
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411155357.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-12
Estimated Expiration
2044-08-22

AI Technical Summary

Technical Problem

The existing drugs for treating alcohol poisoning are difficult to effectively improve patients' symptoms such as dizziness, physical weakness, thirst, bitter taste, nausea, and dryness, heat and anorexia. It lacks the effect of protecting the liver and strengthening the spleen, affecting the rapid recovery of patients' health.

Method used

Provide a combination of spleen-strengthening wine, including Pueraria root, Pueraria, chrysanthemum, Scutellaria baicalensis, Buddha hand, Atractylodes, White Peony, Poria cocos, Ginger and Bamboo Root, Peony bark, Jiao Shen Liuqu, Baiji, Tangerine peel, Licorice and Amomum villossus, through thin layers Identification and liquid chromatography to detect the content of white peony and fushima, as well as the content determination of baicalin, to ensure the quality and component ratio of the preparation.

Benefits of technology

This compound has shown significant effects in relieving alcohol and sootheing the spleen, digesting food and stopping vomiting, clearing heat and eliminating dampness, protecting the liver and strengthening the spleen, improving the symptoms of patients, improving the efficacy of treating alcohol poisoning and the quality of life of patients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118937529A_ABST
    Figure CN118937529A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of biological medicines, and particularly relates to a detection method of a mixture for tonifying spleen and dispelling effects of alcohol. In combination with the clinical experience of famous and old traditional Chinese medicine, the prescription is modified and reduced on the basis of a pueraria flower beverage, has the effects of tonifying spleen and protecting liver, promoting digestion and arresting vomiting, and clearing heat and resolving dampness, and is prepared from pueraria flower, kudzu vine root, chrysanthemum, radix scutellariae tablets, fingered citron, bighead atractylodes rhizome, white peony root, poria cocos, ginger bamboo shavings, moutan bark, scorched spirit medicated leaven, rhizoma bletillae, pericarpium citri reticulatae, fructus amomi and liquorice. The preparation is subjected to thin-layer identification, characteristic spectrum analysis and index component quantitative analysis, has the remarkable advantages of simplicity and convenience in operation and use, easiness in popularization and use and the like, and can be applied to product quality analysis of the mixture.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biomedicine, and in particular relates to a detection method for a spleen-strengthening and alcohol-relief mixture. Background Art

[0002] In recent years, with the improvement of people's living standards and changes in drinking habits, the incidence of alcohol poisoning has become increasingly high, and has become the world's third largest public health problem after cardiovascular and cerebrovascular diseases and tumors. Drinking a small amount of alcohol is good for the body, but drinking too much or drinking a lot for a long time can cause acute or chronic alcohol poisoning. The liver is the main organ for ethanol metabolism. The most common complication of alcohol poisoning is alcoholic liver disease, which can also lead to weakened brain inhibition function, weakened or lost discrimination, memory, and comprehension. Vision problems, drowsiness, vomiting, chronic poisoning manifests as cardiovascular disorders, malnutrition, intellectual impairment, chronic gastritis, heart, liver, kidney degeneration and even cirrhosis. After drinking, patients experience symptoms such as physical weakness, thirst, bitter taste in the mouth, bad breath, nausea, nausea, dryness, anorexia, diarrhea and loose stools. Some patients last for several days, seriously affecting their quality of life. Western medicine treatments commonly use naloxone hydrochloride, Xingnaojing injection and other wake-up agents, as well as proton pump inhibitors, vitamin B6 and other stomach protection agents, but the efficacy is generally poor, and it is difficult to improve the patient's symptoms of dizziness, physical weakness, thirst, bitter mouth, bad breath, nausea, dryness, heat and anorexia. Therefore, there is an urgent need for a Chinese medicine compound composition that can protect the liver and spleen while sobering up, so that the human body can quickly recover health.

[0003] (1) Pueraria root

[0004] Pueraria root is the dried root of Pueraria lobata (Willd.) Ohwi, a plant of the Leguminosae family. In the 2020 edition of the Chinese Pharmacopoeia, puerarin is used as the indicator component in the determination of the content of Pueraria root.

[0005] Pueraria root is a Chinese herbal food rich in isoflavones, triterpenes and triterpenoid saponins, coumarins, alkaloids, pueraria polysaccharides and other active ingredients. Pueraria root isoflavones are the main active ingredients, and Pueraria root isoflavones contain more than 20 active ingredients, such as puerarin, daidzein, 3'-hydroxypuerarin, daidzein, genistein, formononetin, irisin, etc. In recent years, the research on the components of Pueraria root has been relatively active. Modern pharmacological studies have shown that its main active ingredient isoflavones have special effects in maintaining the stability of the vascular system and are often used in clinical adjuvant treatment of cardiovascular and cerebrovascular diseases. In addition, based on its functions of anti-oxidative damage, anti-apoptosis, and improvement of blood lipid and blood sugar metabolism, certain progress has also been made in the treatment of diseases such as osteoporosis, alcoholism and premenstrual syndrome.

[0006] (2) Chrysanthemum

[0007] Chrysanthemum is the dried inflorescence of Chrysanthemummorifolium Ramat. of the Asteraceae family. In the 2020 edition of the Chinese Pharmacopoeia, chlorogenic acid is used as a reference substance for thin-layer chromatography identification, and chlorogenic acid, luteolin, and 3,5-O-dicaffeoylquinic acid reference substances are used as indicator components for content determination.

[0008] Chrysanthemum contains a variety of chemical components, mainly flavonoids, volatile oils, phenylpropanoids, terpenes, amino acids, etc., among which flavonoids and phenylpropanoid compounds are the main active ingredients of chrysanthemum. Li Shizhen's "Compendium of Materia Medica" said: Chrysanthemum can benefit the five meridians, regulate the limbs, treat the head, wind and heat; modern pharmacological research shows that chrysanthemum has the effects of heat dissipation, detoxification, improving eyesight, and lowering blood pressure. Its extract can improve myocardial nutrition, remove active oxygen free radicals, strengthen the resistance of capillaries, and reduce the content of fat and cholesterol in the blood; it also has certain effects on curbing tumors, delaying aging and enhancing human immunity.

[0009] (3) Scutellaria baicalensis tablets

[0010] Scutellaria baicalensis is the dried root of Scutellaria baicalensis Georgi, a plant of the Lamiaceae family.

[0011] The chemical composition of Scutellaria baicalensis is diverse, and the main components are: flavonoids, phenolic acids, amino acids, trace elements, etc., among which flavonoids account for a large effective proportion. At present, there are more than 40 flavonoid components whose structures can be identified, including: baicalein, baicalin, 5,7,4-trihydroxy-8-methoxyflavone, oroxylin A-7-glucuronide, etc. In addition to its antibiotic, antiviral, anticancer, analgesic and antipyretic effects, Scutellaria baicalensis also helps protect the liver, immune system and nervous system of the body.

[0012] (4) Buddha’s Hand

[0013] Buddha's hand is the dried fruit of Citrus medica L.var.sarco dactylis Swingle, a plant of the Rutaceae family.

[0014] The chemical components of bergamot mainly include volatile oils, coumarins, flavonoids, polysaccharides, inorganic elements, amino acids and other physiologically active substances (limonene, limonin, dimethoxycoumarin, trihydroxydimethoxyflavone, carotene, β-sitosterol, p-hydroxyphenylacrylate, palmitic acid, succinic acid, limonene dimer, a small amount of diosmin and hesperidin, etc.). It has been found that bergamot has multiple pharmacological activities such as anti-inflammatory, anti-tumor, blood sugar regulation and lipid-lowering. Summary of the invention

[0015] In order to solve the above-mentioned technical problems, this application provides the following technical solutions:

[0016] The invention provides a detection method for a spleen-strengthening and hangover-relief mixture, wherein the spleen-strengthening and hangover-relief mixture comprises kudzu root, kudzu flower, chrysanthemum, scutellaria baicalensis, bergamot, atractylodes macrocephala, white peony root, tuckahoe, ginger bamboo shavings, peony bark, jiaoshenliuqu, bletilla striata, dried orange peel, liquorice and amomum villosum, and the detection method comprises thin layer identification of white peony root and bergamot, and liquid chromatography to determine the content of baicalin, an indicator component in scutellaria baicalensis:

[0017] Wherein, the method for identifying white peony root and bergamot comprises the following steps:

[0018] S11: Take an appropriate amount of the spleen-strengthening and hangover-revitalizing mixture, add ethyl acetate to extract, concentrate and redissolve to obtain a test solution A1;

[0019] S12: Weigh a white peony root control sample or a citron root control sample, and add ethyl acetate to prepare a reference solution B1;

[0020] S13: Spot the test solution A1 and the reference solution B1 on the stationary phase respectively and place them in a developing agent for development, and observe the results after drying;

[0021] The determination of the content of baicalin comprises the following steps:

[0022] S21: Take an appropriate amount of the spleen-strengthening and hangover-relief mixture, add methanol to dilute, and filter to obtain the test solution A2;

[0023] S22: weighing a baicalin reference sample and adding methanol to prepare a reference solution B2;

[0024] S23: respectively aspirate the test solution A2 and the reference solution B2 and inject them into the liquid chromatograph for determination, and establish a linear regression equation according to the concentration and peak area of ​​the determination result of the reference solution B2;

[0025] S24: Determine the content of baicalin in the test solution A2 according to the linear regression equation and the peak area in the measurement result of the test solution A2.

[0026] Preferably, the preparation method of the spleen-strengthening and alcohol-relief mixture comprises the following steps:

[0027] S31: By weight, 30 parts of kudzu root, 30 parts of kudzu flower, 12 parts of chrysanthemum, 10 parts of scutellaria, 10 parts of bergamot, 12 parts of atractylodes, 20 parts of white peony root, 20 parts of tuckahoe, 6 parts of tangerine peel, 10 parts of ginger bamboo, 15 parts of peony bark, 10 parts of jiaoshenliuqu, 3 parts of bletilla striata and 6 parts of liquorice are respectively decocted twice with water, and filtered to obtain filtrates of various medicinal materials; wherein the first decoction method is: adding water 6 times the total weight of solids, soaking for 0.5h, decocting for 0.5h, and filtering; the second decoction method is: adding water 3 times the total weight of solids remaining after filtering in the first decoction, and decocting for 0.5h;

[0028] S32: Mix the filtrate of the medicinal material slices, add 6 parts of Amomum villosum, concentrate under reduced pressure, add stevioside and water, and mix to obtain the spleen-strengthening and alcohol-relief mixture.

[0029] Preferably, in step S32, the mixture is stirred evenly after mixing, filtered, sealed, and sterilized.

[0030] Preferably, the method further comprises a characteristic spectrum analysis method of the drug, specifically: analyzing the liquid phase test sample of the spleen-strengthening and alcohol-revitalizing mixture and the liquid phase test sample of a single medicinal material by liquid chromatography, and using the medicinal material having characteristic index components and not interfering with other components as the index drug in the spleen-strengthening and alcohol-revitalizing mixture; the index drug is selected from Pueraria root, white peony root, chrysanthemum and scutellaria baicalensis;

[0031] The chromatographic conditions of the liquid chromatography method for determining the index drug are as follows:

[0032] The chromatographic column was a carbon 18-modified silica gel column, the flow rate was 1 mL / min, and the injection volume was 20 μL;

[0033] The detector is a DAD detector with a detection wavelength of 200-400nm;

[0034] Mobile phase A is acetonitrile, mobile phase B is 0.1 wt % phosphoric acid aqueous solution, and the total volume of mobile phase A and mobile phase B is 100%;

[0035] Gradient conditions: the volume of mobile phase A is 3% at 0-5 min, 3%-14% at 5-10 min, 14% at 10-15 min, 14% at 15-20 min, 14%-22% at 20-25 min, 22% at 25-30 min, 22%-40% at 30-35 min, 40% at 35-40 min, 40%-100% at 40-45 min, and 100% at 40-45 min; wherein, the detection wavelength of Pueraria lobata is 250 nm; the detection wavelength of white peony root is 230 nm; the detection wavelength of chrysanthemum is 348 nm; and the detection wavelength of Scutellaria baicalensis is 280 nm.

[0036] Preferably, in step S11, the test solution A1 is obtained by extracting the spleen-strengthening and alcohol-relief mixture by shaking with ethyl acetate, evaporating under reduced pressure, and then adding ethyl acetate to dissolve it.

[0037] Furthermore, the shaking extraction is performed twice.

[0038] Preferably, in step S13, when the reference solution B1 is a white peony root reference sample, the developing agent is selected from a mixed solution of chloroform, ethyl acetate, methanol and formic acid; wherein the mass ratio of chloroform, ethyl acetate, methanol and formic acid is 40:5:10:0.2.

[0039] Furthermore, in the step S13, after drying, spray with a color developer and heat at 105°C until color is developed; the color developer is selected from a 5wt% vanillin sulfuric acid ethanol solution; the chromatograms of the test solution A1 and the reference solution B1 are compared, and if blue-purple spots appear at the same position, it indicates that the sample to be tested contains white peony root.

[0040] Preferably, in step S13, when the reference solution B1 is a bergamot reference sample, the developing agent is selected from a mixed solution of cyclohexane and ethyl acetate; wherein the mass ratio of cyclohexane to ethyl acetate is 3:1.

[0041] Furthermore, in the step S13, after drying, the results are observed using a 365nm ultraviolet lamp; the chromatograms of the test solution A1 and the reference solution B1 are compared, and if fluorescent spots appear at the same position in the test sample and the corresponding reference solution, it means that the test sample contains bergamot.

[0042] Preferably, in the steps S22 and S23, methanol is used to prepare a reference solution with a concentration of 20-1040 μg / mL, and the determination is performed under the following chromatographic conditions:

[0043] The chromatographic column was a carbon 18 modified silica gel column, the column temperature was 30°C, the injection volume was 20 μL, the flow rate was 1.0 mL / min, the detector was a DAD detector, and the detection wavelength for baicalin was 280 nm.

[0044] The mobile phase A is a 0.1wt% phosphoric acid aqueous solution, and the mobile phase B is acetonitrile; the total volume of the mobile phase A and the mobile phase B is 100%, and gradient elution is performed; the gradient elution conditions are: the volume of the mobile phase B is 3% during 0-5min, the volume of the mobile phase B is 3%-14% during 5-10min, the volume of the mobile phase B is 14% during 10-15min, the volume of the mobile phase B is 14% during 15-20min, the volume of the mobile phase B is 14-22% during 20-25min, the volume of the mobile phase B is 22% during 25-30min, the volume of the mobile phase B is 22-40% during 30-35min, the volume of the mobile phase B is 40% during 30-40min, the volume of the mobile phase B is 40-95% during 35-40min, the volume of the mobile phase B is 95% during 40-45min, the volume of the mobile phase B is 95% during 45-50min, the volume of the mobile phase B is 95% to 3% during 50-60min, and the volume of the mobile phase B is 3%.

[0045] Preferably, in step S23, the linear regression equation is y=18.806x+62.539, R 2 =0.9999; where y is the peak area, x is the concentration, x = 26-416 μg mL -1 .

[0046] The technical solution of the present invention has the following advantages over the prior art:

[0047] Combined with the clinical experience of famous old Chinese medicine practitioners, the recipe for strengthening the spleen and sobering up is modified and modified on the basis of Gehua Jiedun Decoction, taking into account strengthening the spleen and protecting the liver, digesting food and stopping vomiting, and clearing away heat and dampness. The recipe for strengthening the spleen and sobering up is as follows: Gehua, Gegen, Chrysanthemum, Scutellaria baicalensis slices, Citron, Atractylodes macrocephala, White Peony Root, Poria cocos, Rhizoma Zingiberis, Peony Root, Jiaoshen Liuqu, Bletilla striata, Tangerine Peel, Amomum villosum, and Licorice. In the recipe, Gehua is the main medicine, sobering up and sobering up the spleen; Jiaoshen Liuqu is used as the assistant medicine to digest food and harmonize the stomach, Atractylodes macrocephala strengthens the spleen and dries dampness, White Peony Root softens the liver and nourishes the liver, Amomum villosum stimulates appetite and sobers up the spleen, and Poria cocos promotes diuresis and eliminates dampness; Bamboo striata is used to resolve phlegm and stop vomiting; Gegen promotes fluid production and quenches thirst, Chrysanthemum, Scutellaria baicalensis, and Peony Root clear away heat and detoxify, Bletilla striata protects the stomach and promotes muscle growth, Citron harmonizes the stomach and relieves pain, Tangerine Peel strengthens the spleen and resolves phlegm; Licorice harmonizes all the medicines.

[0048] According to the prescription of the spleen-strengthening and alcohol-revitalizing mixture, the present invention refers to the requirements of the Chinese Pharmacopoeia and relevant guidelines, and conducts thin layer identification, relative density, pH value, solid content and other inspection items, as well as characteristic spectrum analysis and quantitative analysis of index components on the preparation. In the process of developing the spleen-strengthening and alcohol-revitalizing mixture, the present invention finds that the preparation lacks relevant detection methods, and completes the present invention through systematic qualitative and quantitative analysis of the preparation. BRIEF DESCRIPTION OF THE DRAWINGS

[0049] Figure 1 This is a thin layer identification diagram of white peony root; 1 is the white peony root control medicinal material, 2 to 4 are the test samples, and 5 is the white peony root negative control;

[0050] Figure 2 This is a thin layer identification diagram of bergamot; among them, 1 is the bergamot control medicinal material, 2 to 4 are the test samples, and 5 is the bergamot negative control;

[0051] Figure 3 The HPLC characteristic spectrum of the concentrated solution of Jianpi Xinghang Mixture is shown in the figure; the spectra are at 230nm, 250nm, 280nm and 348nm respectively;

[0052] Figure 4 It is the HPLC characteristic spectrum of white peony root in Jianpi Xinghang Mixture at 230nm;

[0053] Figure 5 This is the HPLC characteristic spectrum of the Pueraria root medicinal material in the Jianpi Xinghang mixture at 250nm;

[0054] Figure 6This is the HPLC characteristic spectrum of chrysanthemum in Jianpi Xinghang Mixture at 348nm;

[0055] Figure 7 This is the HPLC characteristic spectrum of the Radix Scutellariae in the Jianpi Xinghang Mixture at 280nm;

[0056] Figure 8 It is the HPLC characteristic spectrum of baicalin reference solution at 280nm;

[0057] Fig. 9 It is the HPLC characteristic spectrum of the test solution at 280nm;

[0058] Fig.10 This is the HPLC characteristic spectrum of the Scutellaria baicalensis negative sample solution at 280nm. DETAILED DESCRIPTION

[0059] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.

[0060] Chinese herbal medicine slices: Pueraria root (batch number: 211117), Pueraria flower (batch number: 220214), Chrysanthemum (batch number: 220531), Scutellaria baicalensis slices (batch number: 220607), Citrus hand (batch number: 220125), Atractylodes macrocephala (batch number: 211010), White peony root (batch number: 220525), Poria (batch number: 211231), Anemarrhena asphodeloides (batch number: 220506), Paeonia suffruticosa (batch number: 220224), Jiaoshenliuqu (batch number: 220527), Bletilla striata (batch number: 220517), Tangerine peel (batch number: 220415), Licorice slices (batch number: 220305), Amomum villosum (batch number: 220321), etc., all of which were purchased from Nantong Mitsukoshi Chinese Herbal Medicine Slices Co., Ltd.

[0061] Control medicinal materials: white peony root control medicinal material, batch number 120905-202011; bergamot root control medicinal material, batch number 120933-201706; scutellaria baicalensis (batch number: 120955-201810); kudzu root (batch number: 121551-201805); all purchased from China Food and Drug Inspection Institute.

[0062] Reagents: Thin layer chromatography silica gel type G, purchased from Qingdao Ocean Chemical Co., Ltd.; analytical grade cyclohexane, chloroform, n-hexane, etc., purchased from Jiangsu Qiangsheng Functional Chemical Co., Ltd.; toluene, acetone, etc., purchased from Yonghua Chemical Co., Ltd.; Wahaha purified water, purchased from Hangzhou Wahaha Group Co., Ltd.

[0063] Example 1 Preparation of mixture and negative sample

[0064] Preparation of the pilot sample of the spleen-strengthening and alcohol-revitalizing mixture: Each batch number (batch numbers are JP20230101, JP20230102, and JP20230103) was prepared according to the preparation method, and 300L and 500mL / bottle were prepared for each batch number.

[0065] The preparation method of the spleen-strengthening and hangover-relief mixture consists of the following steps:

[0066] (1) Prescription composition: 180g of Pueraria root, 180g of Pueraria flower, 72g of Chrysanthemum, 60g of Scutellaria baicalensis slices, 60g of Citrus palm, 72g of Atractylodes macrocephala, 120g of White Peony Root, 120g of Poria, 36g of Tangerine Peel, 60g of Rhizoma Anemarrhenae, 90g of Paeonia suffruticosa, 60g of Scorched Shenliuqu, 18g of Bletilla striata, 36g of Licorice slices, 36g of Amomum villosum (added later), a total of 15 herbs.

[0067] (2) Preparation method: Prepare the medicinal slices according to the prescription amount in (1). Except for Amomum villosum, the remaining 14 medicinal slices are decocted twice with water. For the first time, add 6 times the amount of water for the medicinal slices, soak for 0.5h, decoct for 0.5h, and filter; for the second time, add 3 times the amount of water for the medicinal slices, decoct for 0.5h, and filter. Combine the above filtrates, add Amomum villosum medicinal slices, concentrate under reduced pressure to about 900mL, add an appropriate amount of stevioside, add water to adjust the total amount to 1000mL, stir well, filter, fill, and sterilize.

[0068] Negative control test samples: 15 kinds of negative control test samples lacking single medicinal materials were prepared according to the prescription quantity of the spleen-strengthening and alcohol-relief mixture after removing the corresponding single medicinal materials according to the original prescription. The preparation method was based on the preparation method of the spleen-strengthening and alcohol-relief mixture.

[0069] Single medicinal material test samples: Prepare according to the thin layer identification methods of each medicinal material in the Chinese Pharmacopoeia 2020 edition.

[0070] Reference sample: Puerarin, paeoniflorin, and baicalin reference solution, prepared according to the thin layer identification method of each medicinal material in the Chinese Pharmacopoeia 2020 edition.

[0071] Example 2

[0072] (1) Thin layer chromatography identification of white peony root

[0073] Take 3 batches of samples and shake them evenly (batch numbers are JP20230101, JP20230102, and JP20230103 respectively), measure 20 mL, extract twice with ethyl acetate by shaking, 20 mL each time, take the ethyl acetate layer for reduced pressure evaporation, add 2 mL of ethyl acetate to dissolve the residue as the test solution; weigh 1.0 g of white peony root, add 2 mL of ethyl acetate, shake and extract, as the white peony control solution; take 5 mL of the negative sample lacking white peony root, shake and extract twice with ethyl acetate, 5 mL each time, and obtain the negative control solution lacking white peony root according to the test solution preparation method.

[0074] According to the test under Thin Layer Chromatography 0502 of Part IV of the 2020 edition of the Pharmacopoeia of the People's Republic of China, 10 μL, 10 μL, and 2.5 μL of each of the above three solutions were taken and spotted on the same silica gel G thin layer plate with chloroform-ethyl acetate-methanol-formic acid (40:5:10:0.2) as the developing agent. After development, the plate was taken out, blown dry, sprayed with 5% vanillin sulfuric acid ethanol solution, and heated until the spots were clearly colored.

[0075] The results of thin layer chromatography are shown in Figure 1 .

[0076] The three batches of test samples and the white peony root control medicinal material showed the same blue-purple spots at the corresponding positions on the thin-layer chromatogram. The spots were clear and distinct, with good separation, and there was no interference from the white peony root negative control, so they were included in the detection method.

[0077] (2) Thin layer identification of Buddha's hand

[0078] Take 3 batches of samples and shake them evenly (batch numbers are JP20230101, JP20230102, and JP20230103 respectively), measure 20 mL, extract twice with ethyl acetate by shaking, 20 mL each time, take the ethyl acetate layer and concentrate it to dryness under reduced pressure, add 2 mL of ethyl acetate to dissolve the residue as the test solution; weigh 0.5 g of bergamot medicinal materials, add 5 mL of ethyl acetate, shake and extract, and take the filtrate as the bergamot medicinal material solution; take 5 mL of the negative sample lacking bergamot, shake and extract twice with ethyl acetate, 5 mL each time, and obtain the negative control solution lacking bergamot according to the preparation method of the test solution. According to the experiment under thin layer chromatography item 0502 of Part IV of the 2020 edition of the Pharmacopoeia of the People's Republic of China, 10 μL, 10 μL, and 2.5 μL of each of the above three solutions were taken and spotted on the same silica gel G thin layer plate, respectively, and cyclohexane-ethyl acetate (3:1) was used as the developing agent. The plate was developed, taken out, dried, and examined under ultraviolet light (365 nm) to observe the color position of the fluorescent spots of the test sample and the medicinal material.

[0079] The results of thin layer chromatography are shown in Figure 2 . The thin layer chromatography of the bergamot reference medicinal material shows R f 0.3 as the main fluorescent spot; the three batches of test samples and the bergamot control medicinal materials showed the same main spot in the thin layer chromatographic position, with good separation, and the bergamot negative control had no interference, so they were included in the detection method.

[0080] Example 3

[0081] Three batches of pilot samples, JP20230101, JP20230102, and JP20230103, were used for inspection in accordance with the relevant provisions of Part IV of the Chinese Pharmacopoeia (2020 edition).

[0082] (1) Relative density

[0083] According to the relative density determination method 0601 of Part IV of the 2020 edition of the Chinese Pharmacopoeia, the relative density of three batches of pilot samples was measured (at room temperature). The results are shown in Table 1.

[0084] (2) pH value

[0085] According to the pH value determination method in Part IV of the 2020 edition of the Chinese Pharmacopoeia, pH test paper was used to measure the pH value of three parallel samples. The results are shown in Table 1

[0086] (3) Others

[0087] This product is a multi-dose packaged preparation. It is inspected according to the "volume method" under the [Minimum Fill Inspection Method] (General Rules 0942 of Part IV of the 2020 Edition of the Pharmacopoeia of the People's Republic of China). The filling quantity should comply with the regulations. The results are shown in Table 1.

[0088] (4) Total solids

[0089] Refer to the test of the total solid content determination method (General Rule 3101) in the 2020 edition of the "Chinese Pharmacopoeia". Shake the spleen-strengthening and hangover-relief mixture in advance, use a pipette to accurately measure 1mL of the spleen-strengthening and hangover-relief mixture into a 50mL evaporating dish (pre-weighed), place it in an oven at 105℃ and dry it to constant weight (the difference between two consecutive weighings should not exceed 5mg), and accurately weigh it. Try to calculate as follows:

[0090]

[0091] Where c x is the total solid content of the test sample, g / mL -1 ; W is the weight of the test sample after constant weight, g; V is the volume of the test sample, mL.

[0092] Reference quality analysis of the concentrated solution of Jianpi Xinghang Mixture: The three samples used were observed to be slightly darker in color than the decoction, with a slight precipitate that is easily dispersed by shaking; the smell is fragrant, and the taste is spicy, slightly sour, and bitter. The content of the concentrated solution fluctuates more than that of the decoction due to the influence of process parameters such as volume change during the preparation process, but it does not affect the stability of the content of the finished product. According to the inspection with reference to the General Rules of the Chinese Pharmacopoeia, the average relative density of the concentrated solution of Jianpi Xinghang Mixture is 1.06 (room temperature), the pH value is 4.6, and the solid content is 10.58%.

[0093] Table 1 Quality analysis of Jianpi Xingjiu mixture

[0094] Serial number Relative density pH Solid content (%) Loading JP20230101 1.06 4.6 10.72 Not less than 500mL JP20230102 1.04 4.6 10.37 Not less than 500mL JP20230103 1.06 4.6 10.64 Not less than 500mL average value 1.05 4.6 10.58 Not less than 500mL

[0095] (5) Microbial limit test

[0096] According to 1105 and 1106 of Part IV of the 2020 edition of the "Chinese Pharmacopoeia", the applicability of the microbial limit test method is investigated and a suitable test method is established.

[0097] According to the results of the applicability investigation, the three batches of pilot samples were counted using the plate method for aerobic bacteria, molds and yeasts; the control bacteria Escherichia coli was detected using conventional methods. The results are shown in Table 2 below.

[0098] Table 2 Results of microbial limit test for three batches of samples

[0099]

[0100] According to the microbial limit test method of 1105 and 1106 in Part IV of the 2020 edition of the Chinese Pharmacopoeia, the total number of aerobic bacteria in each milliliter of Jianpi Xinghang Mixture should be less than 10 2 cfu / mL, the total number of molds and yeasts should be <10 cfu / mL, and Escherichia coli (1mL) should not be detected. All three batches of pilot samples of Jianpi Xinghang Mixture meet the standards.

[0101] Example 4

[0102] The spleen-strengthening and alcohol-revitalizing mixture, related single medicinal materials, negative control medicinal materials, etc. were used as samples to study and establish relevant liquid chromatography conditions, analyze the main chemical components of the preparation and the sources of single medicinal materials, and provide a reference for the present invention.

[0103] (1) Raw materials and reagents

[0104] Decoction pieces, control medicinal materials, and negative control test samples: the same as in Example 1.

[0105] (2) Preparation of test samples

[0106] Preparation of the test solution of the spleen-strengthening and hangover-revitalizing mixture: accurately measure 5 mL of the spleen-strengthening and hangover-revitalizing mixture solution, place it in a 25 mL volumetric flask, add methanol and shake well, dilute to the scale line, let it stand, take an appropriate amount of the solution, filter it with a 0.22 μm organic microporous filter membrane to obtain the test solution.

[0107] Preparation of single medicinal material test solution: Prepare according to the method under the Thin Layer Identification item of each medicinal material in the Chinese Pharmacopoeia 2020 edition.

[0108] ① White Peony Root: Accurately weigh 1.019g of this product, place it in a stoppered conical bottle, accurately add 100ml of 30% ethanol, weigh it, ultrasonicate it for 45 minutes, cool it to room temperature, weigh it again, make up the lost weight with 60% ethanol, shake it well, and let it stand. Take an appropriate amount of solution and filter it with a 0.22μm organic microporous filter membrane to obtain the test solution.

[0109] ② Pueraria root: accurately weigh 1.026g of this product, place it in a stoppered conical bottle, accurately add 100ml of 30% ethanol, weigh it, ultrasonicate it for 45 minutes, cool it to room temperature, weigh it again, make up the lost weight with 30% ethanol, shake it well, let it stand. Take an appropriate amount of solution, filter it with a 0.22μm organic microporous filter membrane, and you will get the test solution.

[0110] ③ Scutellaria baicalensis: accurately weigh 1.001g of this product, place it in a stoppered conical bottle, accurately add 100ml of 70% ethanol, weigh it, ultrasonicate it for 45 minutes, cool it to room temperature, weigh it again, make up the lost weight with 70% ethanol, shake it well, let it stand. Take an appropriate amount of solution, filter it with a 0.22μm organic microporous filter membrane, and you will get the test solution.

[0111] ④ Chrysanthemum: Accurately weigh 1.01g of this product, place it in a stoppered conical bottle, accurately add 100ml of 70% methanol, seal it, weigh it, ultrasonically treat it for 45 minutes, let it cool, weigh it again, make up the lost weight with 70% methanol, shake it well, and let it stand. Take an appropriate amount of solution and filter it with a 0.22μm organic microporous filter membrane to obtain the test solution.

[0112] (3) Chromatographic conditions

[0113] Agilent 1260 InfinityⅡ (DAD detector) system, Agilent Technologies, Inc., USA. The chromatographic column was Cosmosil 5C18-MS-Ⅱ (4.6 mm×250 mm, 5 μm); the mobile phase was acetonitrile (A)-0.1% phosphoric acid aqueous solution (B) for gradient elution (0-5 min, 3% A; 5-10 min, 3%-14% A; 10-15 min, 14% A; 15-20 min, 14%-22% A; 20-25 min, 22% A; 25-30 min, 22%-40% A; 30-35 min, 40% A; 35-40 min, 40%-100% A; 40-45 min, 100% A); the detection wavelength was 200-400 nm full wavelength; the flow rate was 1.0 mL·min -1 ; Injection volume 20μL.

[0114] (4) Results

[0115] The characteristic spectrum test results of Jianpi Xingjiu Mixture are as follows Figure 3 Under the above optimized chromatographic conditions, the mixture has 4 main characteristic peaks. Figures 4 to 7) were compared with the Chinese Pharmacopoeia and related literature, and it was confirmed that chromatographic peak 1 (puerarin) came from Pueraria root, peak 2 (peonidin) came from white peony root, peak 3 came from chrysanthemum, and peak 4 came from (baicalin) Scutellaria baicalensis. For other medicinal flavors, the main chromatographic peaks of each medicinal material may not be detected because its characteristic components are fat-soluble components or the corresponding content of the medicinal materials in the mixture is low.

[0116] In Jianpi Xinghang Mixture, the main components that can be identified are from Pueraria root, white peony root, chrysanthemum and scutellaria baicalensis, which are consistent with the results of thin layer identification, and this main component can be selected for subsequent content analysis. In addition, the components and separation degree in the characteristic spectrum of this preparation are poor.

[0117] Example 5

[0118] Based on the above thin layer identification and characteristic analysis results, the content of baicalin, the main ingredient in the preparation, was determined.

[0119] (1) Raw materials, reagents and methods

[0120] Ⅰ Experimental instruments, raw materials and reagents

[0121] Experimental instruments: Agilent 1260 InfinityⅡ (DAD detector): Agilent Technologies, Inc., USA; FA1004 electronic balance: Shanghai Sunny Hengping Scientific Instrument Co., Ltd.

[0122] Baicalin (batch number 110715-202223, content 97.2%): Shanghai Yuanye Biotechnology Co., Ltd.; Jianpi Xinghang mixture, negative sample lacking scutellaria baicalensis: Hai'an Traditional Chinese Medicine Hospital; Scutellaria baicalensis (batch number: 33-1-05): Nantong Mitsukoshi Chinese Medicine Pieces Co., Ltd.; HPLC grade methanol and acetonitrile: Swedish OCEANPAK; chromatographic grade phosphoric acid: Shanghai Aladdin Biochemical Technology Co., Ltd.; Wahaha purified water: Hangzhou Wahaha Group Co., Ltd.

[0123] Ⅱ Preparation of test samples

[0124] Preparation of the test solution of Jianpi Xinghang Mixture: accurately measure 2 mL of Jianpi Xinghang Mixture solution, place it in a 25 mL volumetric flask, add methanol, shake well, dilute to the mark, let it stand, take an appropriate amount of solution to pass through a 0.22 μm organic microporous filter membrane, and take the filtrate. Prepare the negative sample lacking Scutellaria baicalensis in the same way.

[0125] Preparation of reference solution: Accurately weigh 10.40 mg of baicalin reference substance, place in a 10 mL volumetric flask, add appropriate amount of methanol and ultrasonically dissolve, cool to room temperature and then dilute to volume as reference substance stock solution, in which the mass concentration of baicalin is 1040 μg mL -1 .

[0126] Reference medicinal material: accurately weigh 1.001g of Scutellaria baicalensis, place in a stoppered conical bottle, accurately add 100ml of 70% ethanol, weigh, ultrasonicate for 45min, cool to room temperature, weigh again, make up the lost weight with 70% ethanol, shake well, let stand. Take an appropriate amount of solution, filter with a 0.22μm organic microporous filter membrane to obtain the reference medicinal material solution.

[0127] ⅢChromatographic conditions

[0128] The chromatographic column is Cosmosil 5C 18 -MS-Ⅱ (250mm×4.6mm, 5μm); acetonitrile (B)-0.1% phosphoric acid aqueous solution (A) as mobile phase gradient elution (0-5min, 3% B; 5-10min, 3%-14% B; 10-15min, 14% B; 15-20min, 14%-22% B; 20-25min, 22% B; 25-30min, 22%-40% B; 30-35min, 40% B; 35-40min, 40%-95% B; 40-45min, 95% B; 45-50min, 95%-3% B; 50-60min, 3% B); the detection wavelength of baicalin was 280nm; the flow rate was 1.0mL·min -1 ; Column temperature 30℃; Injection volume 20μL.

[0129] (2) Methodological investigation

[0130] Ⅰ Specificity results inspection

[0131] Accurately pipette 20 μL of reference solution and test solution, and inject according to the above chromatographic conditions to examine the specificity of the method.

[0132] Results: The results of the property inspection are shown in Figures 8 to 10 Compared with the reference solution and the reference medicinal material, the chromatogram of the test solution showed a chromatographic peak with the same retention time at the same detection wavelength, and the negative sample solution lacking Scutellaria baicalensis had no corresponding chromatographic peak. This shows that there is no interference with the negative sample and the specificity of this method is good.

[0133] Ⅱ Investigation of linear relationship

[0134] Accurately pipette 0.25, 0.5, 1, 2, 3, and 4 mL of the reference stock solution into a 10 mL volumetric flask, add methanol to the mark, shake well, filter through a 0.22 μm organic microporous filter membrane, and take the filtrate to prepare a baicalin mass concentration of 26.00 μg mL -1 , 52.00μg·mL -1 , 104.0 μg·mL -1 , 208.0 μg·mL -1 、312.0μg·mL -1, 416.0 μg·mL -1 A series of reference solutions, each with 6 concentrations. The samples were injected and analyzed according to the above chromatographic conditions. The mass concentration of the reference solution (μg·mL -1 ) is the abscissa (x), the peak area integral value is the ordinate (y), and the linear regression equation and range are calculated.

[0135] Results: The regression equation of baicalin was y=18.806x+62.539, R 2 =0.9999, baicalin concentration is 26.00~416.0μg·mL -1 The linear relationship is good within the range.

[0136] ⅢPrecision inspection

[0137] The concentration of baicalin was 208.0 μg·mL under the linear relationship investigation. -1 20 μL of the reference solution was accurately drawn and injected 6 times under the above chromatographic conditions and measured in sequence. The relative standard deviation (RSD) of the chromatographic peak area of ​​baicalin was calculated to examine the precision.

[0138] The results of precision investigation are shown in Table 3. The results of precision investigation showed that the RSD of the baicalin peak area was 0.13%, and the instrument precision was good.

[0139] Table 3 Results of precision study on the determination of baicalin content in Jianpi Xingjiu mixture

[0140] serial number 1 2 3 4 5 6 RSD% Peak area 3823 3818 3828 3830 3832 3825 0.13

[0141] IV. Repeatability Study

[0142] Take 6 portions of the same batch of Jianpi Xinghang Mixture, prepare the test solution according to the above test solution preparation method, accurately pipette 20 μL, and inject and measure according to the above chromatographic conditions. Calculate the RSD value of the peak area of ​​baicalin chromatographic peak to examine the repeatability.

[0143] The results of the repeatability test are shown in Table 4. The results of the repeatability test showed that the peak area RSD of baicalin was 0.45%, with good reproducibility, which was suitable for this test sample preparation method.

[0144] Table 4 Repeatability test results of baicalin content determination in Jianpi Xingjiu mixture

[0145] serial number 1 2 3 4 5 6 RSD% Peak area 2881 2914 2898 2910 2887 2891 0.45

[0146] Ⅴ Stability investigation

[0147] Accurately pipette 2mL of Jianpi Xinghang mixture, prepare the test solution according to the test solution preparation method, accurately pipette 20μL of the test solution, and inject and measure at 0, 2, 4, 8, 12, and 24h according to the above chromatographic conditions. Calculate the RSD value of the peak area of ​​baicalin chromatographic peak to examine the stability.

[0148] The results of the stability investigation are shown in Table 5. The results show that the RSD of the baicalin peak area is 0.82%, and the test solution has good stability within 24 hours.

[0149] Table 5 Stability test results of baicalin content determination in Jianpi Xingjiu mixture

[0150] Time (h) 1 2 3 4 5 6 average value RSD% Peak area 2781 2774 2792 2783 2816 2834 2797 0.82

[0151] Ⅵ Sample recovery rate

[0152] Accurately pipette 0.5 mL of the spleen-strengthening and hangover-refreshing mixture with a known baicalin content into a 5 mL volumetric flask, and accurately add the reference solution of baicalin (150.2 μg mL -1 )1mL, treat according to the test solution preparation method, prepare 6 copies in parallel, take an appropriate amount of solution to pass through a 0.22μm organic microporous filter membrane, take the filtrate to obtain the test solution. Determine the peak area of ​​the baicalin chromatographic peak in the test solution according to the above chromatographic conditions, calculate the concentration of baicalin in the test solution, and then calculate the sample recovery rate (sample recovery rate (%) = (specified sample measurement value - sample measurement value) / spiked amount × 100%).

[0153] The recovery results are shown in Table 6. The average recovery of baicalin was %, ranging from 95.00% to 105.00%, and the RSD value was 0.34%, indicating that this method can be used for the determination of baicalin in Jianpi Xingjiu mixture.

[0154] Table 6 Results of sample recovery for determination of baicalin in Jianpixinghanghuo mixture

[0155]

[0156] (3) Content of baicalin in Jianpi Xingjiu Mixture

[0157] Three batches of test solutions of Jianpi Xinghang Mixture were prepared according to the test solution preparation method under item (1) of this embodiment. Samples were injected and measured according to the chromatographic conditions under item (1) of this embodiment. Two parallel samples in each batch were injected once each, and the results were averaged. The content determination results of the three batches of Jianpi Xinghang Mixture are shown in Table 7. The baicalin content of the three batches of the mixture ranged from 1.231 to 1.286 mg·mL -1 within the range.

[0158] Table 7 Results of determination of baicalin content in three batches of Jianpi Xingjiu mixture

[0159]

[0160] (4) Summary

[0161] The present invention establishes a method for determining baicalin in a spleen-strengthening and alcohol-revitalizing mixture, and the determination results of three batches of test samples show that the contents of two index components are stable, and the detection method is feasible.

[0162] During the research process of the present invention, it was found that the content of baicalin in the test sample was stable and could be selected as an indicator component for investigation in the detection method.

[0163] Obviously, the above embodiments are merely examples for clear explanation and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived from these are still within the protection scope of the invention.

Claims

1. A method for detecting a spleen-strengthening and hangover-relief mixture, wherein the spleen-strengthening and hangover-relief mixture comprises kudzu root, kudzu flower, chrysanthemum, scutellaria baicalensis, bergamot, atractylodes macrocephala, white peony root, tuckahoe, ginger bamboo shavings, peony bark, jiaoshenliuqu, bletilla striata, tangerine peel, liquorice and amomum villosum, characterized in that: The detection method includes thin layer identification of white peony root and bergamot root, and liquid chromatography to determine the content of baicalin, an indicator component in scutellaria baicalensis root; Wherein, the method for identifying white peony root and bergamot root comprises the following steps: S11: Take an appropriate amount of the spleen-strengthening and alcohol-revitalizing mixture, add ethyl acetate to extract, concentrate and redissolve to obtain a test solution A1; S12: Weigh a white peony root control sample or a citron root control sample, and add ethyl acetate to prepare a reference solution B1; S13: Spot the test solution A1 and the reference solution B1 on the stationary phase respectively and place them in a developing agent for development, and observe the results after drying; The determination of the content of baicalin comprises the following steps: S21: Take an appropriate amount of the spleen-strengthening and hangover-relief mixture, add methanol to dilute, and filter to obtain the test solution A2; S22: weighing a baicalin reference sample and adding methanol to prepare a reference solution B2; S23: respectively aspirate the test solution A2 and the reference solution B2 and inject them into the liquid chromatograph for determination, and establish a linear regression equation according to the concentration and peak area of ​​the determination result of the reference solution B2; S24: Determine the content of baicalin in the test solution A2 according to the linear regression equation and the peak area in the measurement result of the test solution A2.

2. The detection method of the spleen-strengthening and alcohol-relief mixture as claimed in claim 1, characterized in that: The preparation method of the spleen-strengthening and hangover-relief mixture comprises the following steps: S31: By weight, 30 parts of kudzu root, 30 parts of kudzu flower, 12 parts of chrysanthemum, 10 parts of scutellaria, 10 parts of bergamot, 12 parts of atractylodes, 20 parts of white peony root, 20 parts of tuckahoe, 6 parts of tangerine peel, 10 parts of ginger bamboo, 15 parts of peony bark, 10 parts of jiaoshenliuqu, 3 parts of bletilla striata and 6 parts of liquorice are respectively decocted twice with water, and filtered to obtain filtrates of various medicinal materials; wherein the first decoction method is: adding water 6 times the total weight of solids, soaking for 0.5h, decocting for 0.5h, and filtering; the second decoction method is: adding water 3 times the total weight of solids remaining after filtering in the first decoction, and decocting for 0.5h; S32: Mix the filtrate of the medicinal material slices, add 6 parts of Amomum villosum, concentrate under reduced pressure, add stevioside and water, and mix to obtain the spleen-strengthening and alcohol-relief mixture.

3. The detection method of the spleen-strengthening and alcohol-relief mixture as claimed in claim 1, characterized in that: The invention also includes a characteristic spectrum analysis method of the drug, specifically: analyzing the liquid phase test sample of the spleen-strengthening and alcohol-revitalizing mixture and the liquid phase test sample of a single medicinal material by liquid chromatography, and using the medicinal material having characteristic index components and not interfering with other components as the index drug in the spleen-strengthening and alcohol-revitalizing mixture; the index drug is selected from Pueraria root, white peony root, chrysanthemum and scutellaria baicalensis; The chromatographic conditions of the liquid chromatography method for determining the index drug are as follows: The chromatographic column was a carbon 18-modified silica gel column, the flow rate was 1 mL / min, and the injection volume was 20 μL; The detector is a DAD detector with a detection wavelength of 200-400nm; Mobile phase A is acetonitrile, mobile phase B is 0.1 wt % phosphoric acid aqueous solution, and the total volume of mobile phase A and mobile phase B is 100%; Gradient conditions: the volume of mobile phase A is 3% at 0-5 min, 3%-14% at 5-10 min, 14% at 10-15 min, 14% at 15-20 min, 14%-22% at 20-25 min, 22% at 25-30 min, 22%-40% at 30-35 min, 40% at 35-40 min, 40%-100% at 40-45 min, and 100% at 40-45 min; wherein, the detection wavelength of Pueraria lobata is 250 nm; the detection wavelength of white peony root is 230 nm; the detection wavelength of chrysanthemum is 348 nm; and the detection wavelength of Scutellaria baicalensis is 280 nm.

4. The detection method of the spleen-strengthening and alcohol-relief mixture as claimed in claim 1, characterized in that: In the step S11, the test solution A1 is obtained by extracting the spleen-strengthening and hangover-relief mixture twice by shaking with ethyl acetate, evaporating under reduced pressure, and then adding ethyl acetate to dissolve it.

5. The detection method of the spleen-strengthening and alcohol-relief mixture as claimed in claim 1, characterized in that: In step S13, when the reference solution B1 is a white peony root reference sample, the developing agent is selected from a mixed solution of chloroform, ethyl acetate, methanol and formic acid; wherein the mass ratio of chloroform, ethyl acetate, methanol and formic acid is 40:5:10:0.

2.

6. The detection method of the spleen-strengthening and alcohol-relief mixture as claimed in claim 5, characterized in that: In the step S13, after drying, spray with a color developer and heat at 105°C until color is developed; the color developer is selected from a 5 wt% vanillin sulfuric acid ethanol solution; the chromatograms of the test solution A1 and the reference solution B1 are compared, and if blue-purple spots appear at the same position, it means that the sample to be tested contains white peony root.

7. The detection method of the spleen-strengthening and alcohol-relief mixture as claimed in claim 1, characterized in that: In the step S13, when the reference solution B1 is a bergamot reference sample, the developing agent is selected from a mixed solution of cyclohexane and ethyl acetate; wherein the mass ratio of cyclohexane to ethyl acetate is 3:

1.

8. The detection method of the spleen-strengthening and alcohol-relief mixture as claimed in claim 7, characterized in that: In the step S13, after drying, the results are observed using a 365nm ultraviolet lamp; the chromatograms of the test solution A1 and the reference solution B1 are compared, and if fluorescent spots appear at the same position in the test sample and the corresponding reference solution, it means that the test sample contains bergamot.

9. The detection method of the spleen-strengthening and alcohol-relief mixture as claimed in claim 1, characterized in that: In the steps S22 and S23, methanol is used to prepare a reference solution with a concentration of 20-1040 μg / mL, and the measurement is performed under the following chromatographic conditions: The chromatographic column is a carbon 18 modified silica gel chromatographic column, the column temperature is 30°C; the injection volume is 20 μL; the flow rate is 1.0 mL / min; the detector is a DAD detector, and the detection wavelength for determining baicalin is 280 nm.

10. The detection method of the spleen-strengthening and alcohol-relief mixture as claimed in claim 9, characterized in that: When the chromatography is used for determination, the mobile phase A is a 0.1wt% phosphoric acid aqueous solution, and the mobile phase B is acetonitrile; the total volume of the mobile phase A and the mobile phase B is 100%, and gradient elution is performed; the gradient elution conditions are: the volume of the mobile phase B is 3% during 0-5min, the volume of the mobile phase B is 3%-14% during 5-10min, the volume of the mobile phase B is 14% during 10-15min, the volume of the mobile phase B is 14% during 15-20min, the volume of the mobile phase B is 14-22% during 20-25min, the volume of the mobile phase B is 22% during 25-30min, the volume of the mobile phase B is 22-40% during 30-35min, the volume of the mobile phase B is 40% during 30-40min, the volume of the mobile phase B is 40-95% during 35-40min, the volume of the mobile phase B is 95% during 40-45min, the volume of the mobile phase B is 95% during 45-50min, the volume of the mobile phase B is 95% to 3% during 50-60min, and the volume of the mobile phase B is 3%.

Citation Information

Patent Citations

  • Quality control method of siberian cocklebur fruit capsule for treating rhinitis

    CN101474255A

  • Traditional Chinese medicine composition for preventing and treating liver injury and preparation method thereof

    CN111671792A

  • Detection method of intestine-strengthening and diarrhea-stopping mixture

    CN114354813A

  • Traditional Chinese medicine compound composition for protecting liver, tonifying spleen and dispelling effects of alcohol as well as preparation method and application of traditional Chinese medicine compound composition

    CN118340855A

  • Method for determining fingerprint of traditional chinese medicine composition

    WO2023024322A1